Hederacolchiside A1 NEW
| Price | $40 | $123 | $179 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-11-10 |
Product Details
| Product Name: Hederacolchiside A1 | CAS No.: 106577-39-3 |
| Purity: 99.54% | Supply Ability: 10g |
| Release date: 2025/11/10 |
Product Introduction
Bioactivity
| Name | Hederacolchiside A1 |
| Description | Hederacolchiside A1 (Raddeanoside R13) shows anti-leishmanial activity, it exhibits a strong antiproliferative activity on all stages of development of the parasite by altering membrane integrity and potential. Hederacolchiside A1 shows antiproliferation activities in three cancer cell lines with the IC50 value of 2.4 uM, it exhibits a preferential cytotoxicity on a pigmented melanoma cell line. It suppresses proliferation of tumor cells by inducing apoptosis through modulating PI3K/Akt/mTOR signaling pathway. |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 83.3 mg/mL (92.85 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 3.3 mg/mL (3.68 mM), Sonication is recommended. |
| Keywords | Protein kinase B | PKB | PI3K | Phosphoinositide 3-kinase | Parasite | mTOR | MEK | Mammalian target of Rapamycin | Inhibitor | inhibit | Hederacolchiside A-1 | Hederacolchiside A1 | Hederacolchiside A 1 | ERK | Apoptosis | Akt |
| Inhibitors Related | Stavudine | Cysteamine hydrochloride | Kojic acid | Sodium 4-phenylbutyrate | Urethane | L-Ascorbic acid | Hydroxychloroquine | L-Glutamic acid | Doxycycline | Tributyrin | L-Ascorbic acid sodium salt | Alginic acid |
| Related Compound Libraries | Anti-Tumor Natural Product Library | Terpene Natural Product Library | Anti-Parasitic Compound Library | Bioactive Compound Library | Pain-Related Compound Library | Kinase Inhibitor Library | Selected Plant-Sourced Compound Library | Natural Product Library | Antiparasitic Natural Product Library | Anti-infective Natural Product Library | Immunology/Inflammation Compound Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/1g |
VIP5Y
|
XIAMEN SINOPEG BIOTECH CO., LTD.
|
2024-07-30 | |
| $2180.00/50mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-10-27 | |
| $0.00/1kg |
VIP2Y
|
Shandong Hanjiang Chemical Co., Ltd
|
2024-01-10 | |
| $0.00/5mg |
Shanghai Standard Technology Co., Ltd.
|
2020-04-21 | ||
| $9.80/1KG |
VIP6Y
|
Career Henan Chemical Co
|
2020-02-06 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY